Namenda
Intended to relieve progressive cognitive decline to support memory retention and target central glutamate activity.
Namenda details
- Alternative names
- memantine
- Therapeutic class
- NMDA Receptor Antagonist
- Pharmacological class
- Alzheimer's Disease Therapy
- Known off-label uses
- vascular dementia
- Contraindications
- severe hypersensitivity to memantine
- Minor side effects
- dizziness; headache; confusion
- Moderate side effects
- constipation; somnolence; hypertension
- Serious side effects
- severe hypersensitivity anaphylaxis, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Originator
- Forest Laboratories
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Amantadine; Acetazolamide
- Age restrictions
- Approved for adults.
Patient summary
intended to relieve progressive cognitive decline to support memory retention and target central glutamate activity.
Mechanism of action
Acts as an uncompetitive antagonist at NMDA glutamate receptors, blocking background excitotoxicity while permitting physiological signaling.
Pregnancy and breastfeeding
TGA Category B: Safety established in animal models. Breastfeeding: Consult a doctor.
What you will receive
Namenda is the originator brand name, made by Forest Laboratories. We use it to identify the medicine and are not affiliated with Forest Laboratories.
- The fulfilment partner confirms whether the exact brand or an equivalent containing Memantine is offered.
- The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
- Check the final product details at checkout before confirming an order.